Search research articles
Contact Us
Filters
Showing results (1-10 of 143) with videos related to
Page
of 15
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
September 28, 2016
Consolidation therapy after autologous stem cell transplant in relapsed/refractory Hodgkin lymphoma
Craig H Moskowitz
Hematology. American Society of Hematology. Education Program
|
December 13, 2012
Interim PET-CT in the management of diffuse large B-cell lymphoma
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
October 17, 2017
Highlights in Lymphoma From the 2017 ASCO Meeting and the 14th ICML: Commentary
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
October 10, 2015
Highlights in Lymphoma From the 13th International Conference on Malignant Lymphoma. A Review of Selected Presentations From the 13th International Conference on Malignant Lymphoma • June 17-20, 2015 • Lugano, Switzerland
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
May 10, 2018
Highlights in lymphoma from the 2017 American Society of Hematology Meeting: commentary
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
February 24, 2006
Mantle cell lymphomas
Craig H Moskowitz
Blood Advances
|
April 12, 2018
Should all patients with HL who relapse after ASCT be considered for allogeneic SCT? A consult, yes; a transplant, not necessarily
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
March 14, 2015
Highlights in lymphoma from the 2014 European Hematology Association Congress
Craig H Moskowitz
Seminars in Hematology
|
March 26, 2015
Current status of the role of PET imaging in diffuse large B-cell lymphoma
Craig H Moskowitz, Heiko Schöder
Clinical Advances in Hematology & Oncology : H&O
|
May 10, 2018
Checkpoint inhibition in lymphoma
Gunjan L Shah, Craig H Moskowitz
Page
of 15
Search research articles
Search
Showing results (1-10 of 143) with videos related to
Sort By:
Page
of 15
Clinical Advances in Hematology & Oncology : H&O
|
September 28, 2016
Consolidation therapy after autologous stem cell transplant in relapsed/refractory Hodgkin lymphoma
Craig H Moskowitz
Hematology. American Society of Hematology. Education Program
|
December 13, 2012
Interim PET-CT in the management of diffuse large B-cell lymphoma
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
October 17, 2017
Highlights in Lymphoma From the 2017 ASCO Meeting and the 14th ICML: Commentary
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
October 10, 2015
Highlights in Lymphoma From the 13th International Conference on Malignant Lymphoma. A Review of Selected Presentations From the 13th International Conference on Malignant Lymphoma • June 17-20, 2015 • Lugano, Switzerland
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
May 10, 2018
Highlights in lymphoma from the 2017 American Society of Hematology Meeting: commentary
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
February 24, 2006
Mantle cell lymphomas
Craig H Moskowitz
Blood Advances
|
April 12, 2018
Should all patients with HL who relapse after ASCT be considered for allogeneic SCT? A consult, yes; a transplant, not necessarily
Craig H Moskowitz
Clinical Advances in Hematology & Oncology : H&O
|
March 14, 2015
Highlights in lymphoma from the 2014 European Hematology Association Congress
Craig H Moskowitz
Seminars in Hematology
|
March 26, 2015
Current status of the role of PET imaging in diffuse large B-cell lymphoma
Craig H Moskowitz, Heiko Schöder
Clinical Advances in Hematology & Oncology : H&O
|
May 10, 2018
Checkpoint inhibition in lymphoma
Gunjan L Shah, Craig H Moskowitz
Page
of 15